TrovaGene Inc. NEW

(TROVD) Trade

By |

Profile

Cardiff Oncology Inc is a clinical-stage company with the singular mission of developing new treatment options for cancer patients. Its objective is to overcome resistance, extend duration of response and increase overall survival.

Contact Information

Website: www.cardiffoncology.com
Email: ir@trovagene.com
Main Phone: +1 858 952-7570
Address: 11055 Flintkote Avenue
Address 2: Suite B
State: CA
City / Town: San Diego
Country: US
Postal Code: 92121

Issuer Information

Exchange: NSC
CEO: Mark Erlander
Employees: 14
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)

Equities News

Profile

Cardiff Oncology Inc is a clinical-stage company with the singular mission of developing new treatment options for cancer patients. Its objective is to overcome resistance, extend duration of response and increase overall survival.

Contact Information

Website: www.cardiffoncology.com
Email: ir@trovagene.com
Main Phone: +1 858 952-7570
Address: 11055 Flintkote Avenue
Address 2: Suite B
State: CA
City / Town: San Diego
Country: US
Postal Code: 92121

Issuer Information

Exchange: NSC
CEO: Mark Erlander
Employees: 14
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume 0 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 25,000,000.00 EPS (TTM) -1.97 PE Ratio N/A Exchange NCM
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 12 12 12 12
Low Target Price Estimate 8 8 8 8
Mean Target Price Estimate 9.2 9.2 9.2 9.2
Standard Deviation 1.79 1.79 1.79 1.79
Date of Most Recent Estimate 04/04/16 04/04/16 04/04/16 04/04/16
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 4 4 5 5
Moderate Buy 0 0 0 0
Hold 1 1 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.4 1.4 1 1